Prolira makers of DeltaScan®
Utrecht
About Prolira makers of DeltaScan®
Prolira is committed to enabling early and effective treatment of acute encephalopathy and delirium. Every year, 20 million patients are at risk of acute brain failure in EU and US hospitals, which leads to long-term cognitive impairment, extended hospital stays, and increased healthcare costs. Prolira’s DeltaScan® Brain State Monitor is the world’s first EEG bedside device with a validated proprietary algorithm to support clinicians in their quest to optimize patient recovery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.7M
- Last round: Series Unknown (Feb 2022)
- Website: prolira.comen
- Phone: +31 (0)85 060 1656
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Hospital, Medical
Social Profiles
Canonical: https://fsome.com/organization/prolira-makers-of-deltascan-40163 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.